1.1 Articolo in rivista

1.1 Articolo in rivista: [23569] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 3.781 a 3.800 di 23.569

Hsp60 response in experimental and human temporal lobe epilepsy

2015-01-01 Gammazza, A. M.; Colangeli, R.; Orban, G.; Pierucci, M.; Di Gennaro, G.; Lo Bello, M.; D'Aniello, A.; Bucchieri, F.; Pomara, C.; Valentino, M.; Muscat, R.; Benigno, A.; Zummo, G.; De Macario, E. C.; Cappello, F.; Di Giovanni, G.; Macario, A. J. L.

A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures

2015-01-01 Venzi, M.; Di Giovanni, G.; Crunelli, V.

Differential Control by 5-HT and 5-HT1A, 2A, 2C Receptors of Phasic and Tonic GABAA Inhibition in the Visual Thalamus

2015-01-01 Crunelli, V.; Di Giovanni, G.

The central role of aquaporins in the pathophysiology of ischemic stroke

2015-01-01 Vella, J.; Zammit, C.; Di Giovanni, G.; Muscat, R.; Valentino, M.

Distinct roles of cortical and pallidal β and γ frequencies in hemiparkinsonian and dyskinetic rats

2016-01-01 Salvade, A.; D'Angelo, V.; Di Giovanni, G.; Tinkhauser, G.; Sancesario, G.; Stadler, C.; Moller, J. C.; Stefani, A.; Kaelin-Lang, A.; Galati, S.

New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders

2016-01-01 Di Giovanni, G.; De Deurwaerdere, P.

Tau protein hyperphosphorylation and aggregation in alzheimer’s disease and other tauopathies, and possible neuroprotective strategies

2016-01-01 Simic, G.; Babic Leko, M.; Wray, S.; Harrington, C.; Delalle, I.; Jovanov-Milosevic, N.; Bazadona, D.; Buee, L.; de Silva, R.; Di Giovanni, G.; Wischik, C.; Hof, P. R.

Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures

2016-01-01 Venzi, M.; David, F.; Bellet, J.; Cavaccini, A.; Bombardi, C.; Crunelli, V.; Di Giovanni, G.

Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis

2017-01-01 Schiavone, S.; Mhillaj, E.; Neri, M.; Morgese, M. G.; Tucci, P.; Bove, M.; Valentino, M.; Di Giovanni, G.; Pomara, C.; Turillazzi, E.; Trabace, L.; Cuomo, V.

The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity

2017-01-01 Colangeli, R.; Pierucci, M.; Benigno, A.; Campiani, G.; Butini, S.; Di Giovanni, G.

Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry

2017-01-01 De Deurwaerdere, P.; Di Giovanni, G.; Millan, M. J.

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

2017-01-01 De Deurwaerdere, P.; Di Giovanni, G.

Monoaminergic neuropathology in Alzheimer's disease

2017-01-01 Simic, G.; Babic Leko, M.; Wray, S.; Harrington, C. R.; Delalle, I.; Jovanov-Milosevic, N.; Bazadona, D.; Buee, L.; de Silva, R.; Di Giovanni, G.; Wischik, C. M.; Hof, P. R.

Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation?

2018-01-01 Lagiere, M.; Bosc, M.; Whitestone, S.; Manem, J.; Elboukhari, H.; Benazzouz, A.; Di Giovanni, G.; De Deurwaerdere, P.

Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence

2018-01-01 Delicata, F.; Bombardi, C.; Pierucci, M.; Di Maio, R.; De Deurwaerdere, P.; Di Giovanni, G.

Animal models of early-stage Parkinson's disease and acute dopamine deficiency to study compensatory neurodegenerative mechanisms

2018-01-01 Grandi, L. C.; Di Giovanni, G.; Galati, S.

Suppression of hyperpolarization-activated cyclic nucleotide-gated channel function in thalamocortical neurons prevents genetically determined and pharmacologically induced absence seizures

2018-01-01 David, F.; Carcak, N.; Furdan, S.; Onat, F.; Gould, T.; Meszaros, A.; Di Giovanni, G.; Hernandez, V. M.; Chan, C. S.; Lorincz, M. L.; Crunelli, V.

Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons

1998-01-01 Di Giovanni, G.; Di Mascio, M.; Di Matteo, V.; Esposito, E.

TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?

2018-01-01 Di Giovanni, G.; De Deurwaerdere, P.

Developmental changes of GABA immunoreactivity in cortico-thalamic networks of an absence seizure model

2018-01-01 Bombardi, C.; Venzi, M.; Crunelli, V.; Di Giovanni, G.

Titolo	Data di pubblicazione	Autore(i)
Hsp60 response in experimental and human temporal lobe epilepsy	1-gen-2015	Gammazza, A. M.; Colangeli, R.; Orban, G.; Pierucci, M.; Di Gennaro, G.; Lo Bello, M.; D'Aniello, A.; Bucchieri, F.; Pomara, C.; Valentino, M.; Muscat, R.; Benigno, A.; Zummo, G.; De Macario, E. C.; Cappello, F.; Di Giovanni, G.; Macario, A. J. L.
A critical evaluation of the gamma-hydroxybutyrate (GHB) model of absence seizures	1-gen-2015	Venzi, M.; Di Giovanni, G.; Crunelli, V.
Differential Control by 5-HT and 5-HT1A, 2A, 2C Receptors of Phasic and Tonic GABAA Inhibition in the Visual Thalamus	1-gen-2015	Crunelli, V.; Di Giovanni, G.
The central role of aquaporins in the pathophysiology of ischemic stroke	1-gen-2015	Vella, J.; Zammit, C.; Di Giovanni, G.; Muscat, R.; Valentino, M.
Distinct roles of cortical and pallidal β and γ frequencies in hemiparkinsonian and dyskinetic rats	1-gen-2016	Salvade, A.; D'Angelo, V.; Di Giovanni, G.; Tinkhauser, G.; Sancesario, G.; Stadler, C.; Moller, J. C.; Stefani, A.; Kaelin-Lang, A.; Galati, S.
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders	1-gen-2016	Di Giovanni, G.; De Deurwaerdere, P.
Tau protein hyperphosphorylation and aggregation in alzheimer’s disease and other tauopathies, and possible neuroprotective strategies	1-gen-2016	Simic, G.; Babic Leko, M.; Wray, S.; Harrington, C.; Delalle, I.; Jovanov-Milosevic, N.; Bazadona, D.; Buee, L.; de Silva, R.; Di Giovanni, G.; Wischik, C.; Hof, P. R.
Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures	1-gen-2016	Venzi, M.; David, F.; Bellet, J.; Cavaccini, A.; Bombardi, C.; Crunelli, V.; Di Giovanni, G.
Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis	1-gen-2017	Schiavone, S.; Mhillaj, E.; Neri, M.; Morgese, M. G.; Tucci, P.; Bove, M.; Valentino, M.; Di Giovanni, G.; Pomara, C.; Turillazzi, E.; Trabace, L.; Cuomo, V.
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity	1-gen-2017	Colangeli, R.; Pierucci, M.; Benigno, A.; Campiani, G.; Butini, S.; Di Giovanni, G.
Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry	1-gen-2017	De Deurwaerdere, P.; Di Giovanni, G.; Millan, M. J.
Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications	1-gen-2017	De Deurwaerdere, P.; Di Giovanni, G.
Monoaminergic neuropathology in Alzheimer's disease	1-gen-2017	Simic, G.; Babic Leko, M.; Wray, S.; Harrington, C. R.; Delalle, I.; Jovanov-Milosevic, N.; Bazadona, D.; Buee, L.; de Silva, R.; Di Giovanni, G.; Wischik, C. M.; Hof, P. R.
Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation?	1-gen-2018	Lagiere, M.; Bosc, M.; Whitestone, S.; Manem, J.; Elboukhari, H.; Benazzouz, A.; Di Giovanni, G.; De Deurwaerdere, P.
Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence	1-gen-2018	Delicata, F.; Bombardi, C.; Pierucci, M.; Di Maio, R.; De Deurwaerdere, P.; Di Giovanni, G.
Animal models of early-stage Parkinson's disease and acute dopamine deficiency to study compensatory neurodegenerative mechanisms	1-gen-2018	Grandi, L. C.; Di Giovanni, G.; Galati, S.
Suppression of hyperpolarization-activated cyclic nucleotide-gated channel function in thalamocortical neurons prevents genetically determined and pharmacologically induced absence seizures	1-gen-2018	David, F.; Carcak, N.; Furdan, S.; Onat, F.; Gould, T.; Meszaros, A.; Di Giovanni, G.; Hernandez, V. M.; Chan, C. S.; Lorincz, M. L.; Crunelli, V.
Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons	1-gen-1998	Di Giovanni, G.; Di Mascio, M.; Di Matteo, V.; Esposito, E.
TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?	1-gen-2018	Di Giovanni, G.; De Deurwaerdere, P.
Developmental changes of GABA immunoreactivity in cortico-thalamic networks of an absence seizure model	1-gen-2018	Bombardi, C.; Venzi, M.; Crunelli, V.; Di Giovanni, G.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 3.781 a 3.800 di 23.569

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext23533
reserved26
open10